ISPOR Launches HEOR News Desk

Oct 18, 2022

ISPOR announced that it has launched its HEOR News Desk, a new offering that selects and aggregates global news related to health economics and outcomes research (HEOR).

Global Expert Panel Publishes New Guidance on Designing and Conducting Real-World Evidence Studies

Oct 11, 2022

Value in Health, the official journal of ISPOR, announced the publication of a new template that provides a set of core recommendations for clear and reproducible real-world evidence study protocols.

ISPOR Europe 2022 Plenaries and Speakers Announced

Oct 4, 2022

ISPOR announced its plenary sessions and speakers for its ISPOR Europe 2022 conference. The conference will be held 6-9 November in Vienna, Austria and focused on the theme, “Collaborating Across Borders: Building and Using Evidence to Enable Access.”

Global Experts Introduce Strategic Action Plan to Accelerate Patient Access to Next-Generation DNA Sequencing in Oncology

Sep 27, 2022

Value & Outcomes Spotlight, the health economics and outcomes research (HEOR) news magazine of ISPOR, announced the publication of a supplement, “A Plan of Action: Accelerating Patient Access to Next-Generation Sequencing in Oncology,” that details the challenges in improving patient access to next-generation DNA sequencing and proposes a plan of action to improve access.

ISPOR Announces Honorees for the 2022 Health Economics and Outcomes Research Awards

Sep 13, 2022

ISPOR announced the recipients of its 2022 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field.

Multinational Health Panel Challenges Recent Change in How Drug Benefit Is Measured in Germany

Aug 31, 2022

Value in Health announced the publication of a new report from the ISPOR Clinical Outcome Assessment Special Interest Group that cautioned the universal applicability of a recent change by German health technology assessment organization, IQWiG, (Institute for Quality and Efficiency in Health Care), regarding the process of assessing the added benefit of drug interventions.

Global Health Panel Publishes New Research Highlighting Ambiguity in Digital Health-Related Definitions

Aug 30, 2022

Value in Health, the official journal of ISPOR, announced the publication of a new report examining 4 umbrella terms—digital health, eHealth, mHealth, and telehealth/telemedicine—and their associated definitions from the perspective of their applicability for outcomes research.

ISPOR Chief Executive Officer Position Summary Posted

Aug 29, 2022

ISPOR announced that the position summary for the Chief Executive Officer and Executive Director position has been posted.

Global Health Panel Publishes New Recommendations for Assessing Health Technology in Multipayer Healthcare Systems

Aug 8, 2022

Value in Health, the official journal of ISPOR, announced the publication of a new report examining the specific challenges of conducting and using health technology assessment in countries with multipayer healthcare systems.

Virtual ISPOR Asia Pacific Summit 2022 Announced

Jul 19, 2022

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its Virtual ISPOR Asia Pacific Summit 2022 that is scheduled for 20-21 September.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×